SES AI Corp (SES)

NYSEConsumer DiscretionaryAuto - PartsSnapshot 2026-10-23

$0.69-4.88%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge SES AI Corp’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	13.22M
EPS	—	-0.031
FY 2026 · Annual
Revenue	$30M–$35M	32.17M
EPS	—	-0.162
FY 2027 · Annual
Revenue	—	66.59M
EPS	—	-0.125

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Increase gross profit above $1.2M quarterly	Gross profit improved from $0.51M to $1.22M recently.	Broken	gross profit falls below $1 million next quarter	Gross profit: $1.147M FY2026-Q2; GAAP. Published target: >= $1.2 million. Target period is not explicitly aligned with this observation. Source published Aug 11, 20261,147,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: f13f904f-383d-4553-9498-e403a6140c50. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Manage legal challenges without major financial harm	A supporting condition in SES AI Corp's published investment case. The stated target is No major legal settlements or penalties.	Intact	Material legal penalties or settlements announced	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Reduce operating losses toward -$17.87M quarterly	The company is reducing losses, with operating income improving from -$23M to -$18M.	Broken	operating losses worsen beyond -$20 million next quarter	Operating income: $-19.196M FY2026-Q2; GAAP. Published target: >= -$17.87 million. Target period is not explicitly aligned with this observation. Source published Aug 11, 2026-19,196,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: f13f904f-383d-4553-9498-e403a6140c50. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Achieve 2026 revenue of $30M-$35M	A primary condition in SES AI Corp's published investment case. The stated target is >= $30 million.	Intact	revenue falls below $30 million in FY26	Revenue: $5.072M FY2026-Q2; GAAP. Published target: >= $30 million. Target period is not explicitly aligned with this observation. Source published Aug 11, 20265,072,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: f13f904f-383d-4553-9498-e403a6140c50. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 2 of 2 supplied transcript quarters. Revenue was $6.711 million in 2026-Q1 and $5.072 million in 2026-Q2, while management reaffirmed full-year 2026 guidance of $30 million to $35 million. The sequential revenue decline makes progress toward the stated growth priority uneven, despite Q2 revenue across all product lines. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	Unavailable	2 / 2
2026-07-25	Unavailable	Unavailable	2 / 2
2026-07-26	Unavailable	Unavailable	2 / 2
2026-07-27	Unavailable	Unavailable	2 / 2
2026-07-28	Unavailable	Unavailable	2 / 3
2026-07-29	Unavailable	Unavailable	2 / 2
2026-07-30	Unavailable	Unavailable	2 / 3
2026-07-31	Unavailable	Unavailable	2 / 2
2026-08-01	Unavailable	Unavailable	2 / 2
2026-08-02	Unavailable	Unavailable	2 / 3
2026-08-03	Unavailable	Unavailable	2 / 3
2026-08-04	Unavailable	Unavailable	2 / 3
2026-08-05	Unavailable	Unavailable	2 / 3
2026-08-06	Unavailable	Unavailable	2 / 3
2026-08-08	Unavailable	Unavailable	2 / 3
2026-08-09	Unavailable	Unavailable	2 / 3
2026-08-10	Unavailable	Unavailable	2 / 3
2026-08-12	Unavailable	Unavailable	2 / 2
2026-08-13	Unavailable	Unavailable	2 / 2
2026-08-14	Unavailable	Unavailable	2 / 2
2026-08-15	Unavailable	Unavailable	2 / 2
2026-08-16	Unavailable	Unavailable	3 / 2
2026-08-17	Unavailable	Unavailable	3 / 2
2026-08-18	Unavailable	Unavailable	2 / 2
2026-08-19	Unavailable	Unavailable	3 / 2
2026-08-20	Unavailable	Unavailable	3 / 2
2026-08-21	Unavailable	Unavailable	3 / 2
2026-08-22	Unavailable	Unavailable	3 / 2
2026-08-23	Unavailable	Unavailable	3 / 2
2026-08-24	Unavailable	Unavailable	3 / 2
2026-08-25	Unavailable	Unavailable	3 / 2
2026-08-26	Unavailable	Unavailable	3 / 2
2026-08-27	Unavailable	Unavailable	3 / 2
2026-08-28	Unavailable	Unavailable	3 / 2
2026-08-29	Unavailable	Unavailable	3 / 2
2026-08-30	Unavailable	Unavailable	3 / 2
2026-08-31	Unavailable	Unavailable	3 / 2
2026-09-01	Unavailable	Unavailable	3 / 2
2026-09-02	Unavailable	Unavailable	3 / 2
2026-09-03	Unavailable	Unavailable	3 / 2
2026-09-04	Unavailable	Unavailable	3 / 2
2026-09-05	Unavailable	Unavailable	3 / 2
2026-09-06	Unavailable	Unavailable	3 / 2
2026-09-07	Unavailable	Unavailable	3 / 2
2026-09-08	Unavailable	Unavailable	3 / 2
2026-09-09	Unavailable	Unavailable	3 / 2
2026-09-10	Unavailable	Unavailable	3 / 2
2026-09-11	Unavailable	Unavailable	3 / 2
2026-09-12	Unavailable	Unavailable	3 / 2
2026-09-13	Unavailable	Unavailable	3 / 2
2026-09-14	Unavailable	Unavailable	3 / 2
2026-09-15	Unavailable	Unavailable	3 / 2
2026-09-16	Unavailable	Unavailable	3 / 2
2026-09-17	Unavailable	Unavailable	3 / 2
2026-09-18	Unavailable	Unavailable	3 / 2
2026-09-19	Unavailable	Unavailable	3 / 2
2026-09-20	Unavailable	Unavailable	3 / 2
2026-09-21	Unavailable	Unavailable	3 / 2
2026-09-22	Unavailable	Unavailable	3 / 2
2026-09-23	Unavailable	Unavailable	3 / 2
2026-09-24	Unavailable	Unavailable	3 / 2
2026-09-25	Unavailable	Unavailable	3 / 2
2026-09-26	Unavailable	Unavailable	3 / 2
2026-09-27	Unavailable	Unavailable	3 / 2
2026-09-28	Unavailable	Unavailable	3 / 2
2026-09-29	Unavailable	Unavailable	3 / 2
2026-09-30	Unavailable	Unavailable	3 / 2
2026-10-01	Unavailable	Unavailable	3 / 2
2026-10-02	Unavailable	Unavailable	3 / 2
2026-10-03	Unavailable	Unavailable	3 / 2
2026-10-04	Unavailable	Unavailable	3 / 2
2026-10-05	Unavailable	Unavailable	3 / 2
2026-10-06	Unavailable	Unavailable	3 / 2
2026-10-07	Unavailable	Unavailable	3 / 2
2026-10-08	Unavailable	Unavailable	3 / 2
2026-10-09	Unavailable	Unavailable	3 / 2
2026-10-10	Unavailable	Unavailable	3 / 2
2026-10-11	Unavailable	Unavailable	3 / 2
2026-10-12	Unavailable	Unavailable	3 / 2
2026-10-13	Unavailable	Unavailable	3 / 2
2026-10-14	Unavailable	Unavailable	3 / 2
2026-10-15	Unavailable	Unavailable	3 / 2
2026-10-16	Unavailable	Unavailable	3 / 2
2026-10-17	Unavailable	Unavailable	3 / 2
2026-10-18	Unavailable	Unavailable	3 / 2
2026-10-19	Unavailable	Unavailable	3 / 2
2026-10-20	Unavailable	Unavailable	3 / 2
2026-10-21	Unavailable	Unavailable	3 / 2
2026-10-22	Unavailable	Unavailable	3 / 2
2026-10-23	Unavailable	Unavailable	3 / 2
2026-10-24	Unavailable	Unavailable	3 / 2

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	1	1
2026-06-01	1	1
2026-07-01	1	1
2026-08-01	1	1
2026-09-01	1	1
2026-10-01	1	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 1 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Increase gross profit above $1.2M quarterlyPublished status: Broken
Manage legal challenges without major financial harmQualitative condition
Reduce operating losses toward -$17.87M quarterlyPublished status: Broken
Achieve 2026 revenue of $30M-$35MRevenue: $5.072M

Next proof point

Nov 12, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

5.0%Typical daily move · historical

Downside history

-80.5%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

SES AI Corp outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a speculative growth business, not an established compounder, because it is loss-making and recent financial performance is weak. The multi-year view is in a watch state, and the signal has shifted from mixed to cautious.

What's priced into SES AI Corp

The evidence snapshot provides no valuation multiple or explicit market expectations, so whether SES is cheap or expensive versus peers cannot be assessed. There is also no clear evidence of what growth or profitability the market already assumes.

What the fundamentals likely do

Near term, the main execution test is reaching 2026 revenue guidance of $30 million to $35 million, after revenue fell sequentially from $6.711 million in Q1 to $5.072 million in Q2. Cost control shows some progress year over year, but operating expenses rose sequentially, and drone-cell production preparation has not yet translated into clearly reported commercial scale.

What SES AI Corp hinges on

The thesis depends on guidance being maintained and production qualifications converting into meaningful revenue; a guidance cut would be a material negative signal. Sector conditions also matter: continued strength among the cited bellwethers could support the backdrop, while weaker results or guidance could remove that support.